Prevail InfoWorks’ Post

Shockwave Medical: The Billion-Dollar Game Changer for J&J MedTech   Johnson & Johnson's Q2 earnings report highlights their acquisition of Shockwave Medical, set to add $500 million in sales by year-end. In just the first 30 days, Shockwave contributed $77 million, showcasing its immediate impact. Chalk, Borrowed from Shockwave’s website:  “In 2009, a marketer, engineer and cardiologist came together to change the nature of interventional therapy for calcified cardiovascular disease. They envisioned a future in which lithotripsy, a trusted technology used to break kidney stones for more than three decades, could be adapted to crack calcium in undilatable lesions in a potentially easier and safer manner. What started out as a crazy idea is now changing the standard of care for patients with calcified disease around the globe.” Have you ever seen a medical device’s revenue ramp up as fast? Share your experience in the comment below. “We closed that transaction in record timing, and we are really excited to shortly announce that they will be the 13th business with sales in excess of $1 billion annually,” added J&J MedTech’s worldwide chairman, Tim Schmid. Find more details in the article linked in the comments. #Biotechnology #HealthcareInnovation #MedTech #JohnsonAndJohnson #ShockwaveMedical #CardiovascularHealth #MedicalAdvancements #HealthcareTech #Innovation #LifeSciences 

Prevail Group Networking and Cocktail Reception Would you like to join us for an evening of networking and engaging conversation? Hosted by Prevail InfoWorks, the full-service CRO & FSP, this event is an excellent opportunity to come together in a relaxed atmosphere to see and be seen. Whether you are in Philadelphia for the AAIC conference or in town for a little fun, please do come by! Located at the lively Ding Feng Tang bar and restaurant on Arch Street between 10th and 11th Avenues, this venue is conveniently situated just 2 blocks from the Pennsylvania Convention Center. Will you be our guest and experience Philly's famous Chinatown with us? More details below. "As we continue our vital work in clinical research, I encourage everyone to join us in Philadelphia for the Alzheimer’s Association International Conference. This event is a unique opportunity to collaborate, share insights, and advance our collective understanding of Alzheimer's disease. Let's gather in this historic city to drive innovation and make a meaningful impact in the fight against Alzheimer's." says Jack Houriet, CEO of Prevail InfoWorks. Event: Prevail Networking and Cocktail Reception   Venue: Ding Feng Tang Bar and Restaurant    Location: 1021 Arch Street, Philadelphia, PA 19107   Date and Time: Monday, July 29th, 5-8PM   RSVP Now: https://lnkd.in/ePFJqtDi #AAIC #Alzheimers #AD #Philly #Philadelphia #PrevailInfoWorks #PrevailPartners #ClinicalDevelopment #ClinicalInnovation #Healthcare #Biotech #Pharma #DingFengTang #Cocktails #Networking

'I’ve invented an alternative to uncomfortable smear tests' Sânziana Foia, a bio-engineering PhD student, has revolutionized cervical cancer screening with the creation of Papcup, a non-invasive, at-home test. Inspired by her own uncomfortable experience with traditional smear tests, Sânziana developed this innovative device to detect HPV using menstrual blood. This breakthrough offers women a private, quick, and painless alternative, potentially increasing early cancer detection rates. Backed by the The University of Edinburgh’s Venture Builder Incubator, Sânziana is paving the way for more comfortable and accessible healthcare solutions. Sânziana said: "If someone gets a positive HPV test then they might want to go and get the full smear test for full diagnosis, where they look in depth at what's going on. But we aim to break through that first barrier that women have towards getting their smear test. "We hope to be able to offer women a much more comfortable screening experience." Sânziana told BBC Scotland News: "It's a small device, about the size of my fist. You add to it a sample of menstrual blood that you collect with a swab. Read more in the article in the comment below. #WomenInScience #Innovation #Healthcare #CervicalCancer #HPV #Bioengineering #WomenInSTEM #Papcup #UniversityOfEdinburgh #SânzianaFoia #Diagnostics

More This Week on Women in BIO Women leaders are driving innovation in biotech, navigating today's challenging funding environment and leveraging AI in drug discovery. Alethia Young, CFO of Bicycle Therapeutics, emphasizes the need for aggressive strategies to secure funding, while Sherrie Glass, Biopharma Strategy and Business Development Leader at Bristol Myers Squibb, highlights the importance of investing in late-stage assets to sustain revenue growth. Their leadership is crucial in shaping the future of biopharma, where AI and strategic investment are set to revolutionize the industry. Just as you will find in the Prevail model. “Biotech assets are ultimately the “lifeblood” of the biopharma pipeline; and biopharma has the firepower and the money to invest in these candidates.” explained Sherrie Glass. Read more in the article in the comment below and visit: prevailinfoworks.com #Biotech #WomenInLeadership #AI #DrugDevelopment #Innovation #Pharma #HealthcareInnovation #Biopharma #InvestmentStrategies #Leadership

Empowering Women in Biotech: Pioneering Cancer Treatments with Caitlyn Miller, CEO of TwoStep Therapeutics Women in Biotech: Caitlyn Miller, PhD CEO of TwoStep Therapeutics, has leveraged her childhood experiences with cancer to drive pioneering advancements in targeted therapies, shaping the future of oncology. Inspired by personal hardship, Caitlyn co-founded TwoStep to revolutionize solid tumor treatment through innovative drug delivery platforms. With a recent $6.5 million seed round, TwoStep is poised to expand its pipeline of tumor-targeting therapies, leveraging PIP, a novel peptide developed for precise and effective treatment delivery. Caitlyn's leadership highlights the pivotal role of women in biotech, driving forward transformative solutions in healthcare. How can we empower more women to lead? “What really drew me into the field of tumor-targeted therapies was seeing that we could design better drugs that would only kill the tumor tissue, but not the healthy tissue,” says Caityln Miller, CEO of TwoStep Therapeutics. Read more in the article in the comment below. #WomenInBiotech #BiotechInnovation #PrecisionMedicine #TargetedTherapies #CancerTreatment #OncologyAdvancements #WomenLeaders #HealthcareInnovation #DrugDelivery #StartupLife #STEMWomen

Breaking Barriers: Coco Brown - Empowering Women to Lead in Boardrooms Worldwide! Women in Business: Coco Brown, PhD, CEO of Athena Alliance, has transformed her early career in tech into a mission-driven path dedicated to empowering women in leadership roles. Inspired by her experiences and driven by the mission to overcome imposter syndrome, Coco has steered Athena Alliance to support over 450 women in securing board roles. What advice would you give to women aspiring to leadership roles in today's competitive business landscape?" “Think much bigger about yourself. What if I could be the CEO? What if I could start investing in companies? And through that, advising on things I care about, and through that, becoming a board member? And what if I could start my own company? Don't limit your thinking,” says Coco. “Make sure you understand where you fit in this landscape so that you can build a real strategy for it, the way kids build a strategy to get into the school they want. That's a big secret to success.” Read more in the article in the comment below. #WomenInLeadership #BoardDiversity #EmpowerWomen #LeadershipDevelopment #ImposterSyndrome #CorporateEquality #InclusiveLeadership #AthenaAlliance #DiverseBoards #StrategicLeadership

Empowering Women in STEM: Morgane Rousselot’s Inspiring Path for Women Morgane Rousselot, co-founder and CEO of SeaBeLife Biotech, took center stage in Drug Target Review’s "Women in STEM" series interview. Morgane’s incredible journey, marked by over 20 years of experience in biotechnology, showcases her dedication to breaking barriers and championing women's roles in science. Her leadership serves as a beacon of inspiration for women to make their mark in STEM fields. Join us in celebrating Morgane’s contributions to healthcare innovation. How can we collectively foster an environment in STEM to support women in reaching leadership and research roles? “Throughout my career, I’ve had the opportunity to work on exciting research projects, collaborate with inspiring colleagues and contribute to significant scientific advancements. However, challenges persist, particularly in balancing professional and personal life as both a woman and mother…” says Moragane Rouseelot, CEO of SeaBeLife. If you would like to read more about this interview, check out the article link in the comments below. #WomenInSTEM #STEMLeadership #Biotechnology #InspiringWomen #GenderEquality #WomenInScience #STEMRoleModels #BreakingBarriers #EmpoweringWomen

Today, we honor the courage and determination of those who fought for our independence and continue to protect our liberties. Let's take a moment to appreciate the vibrant communities that make up this great country. Whether you're enjoying a barbecue with family, watching fireworks with friends, or simply taking a day to relax, let's remember the spirit of togetherness that the 4th of July embodies. At Prevail InfoWorks, we are grateful for the opportunities that freedom provides, and we are committed to contributing positively to our society. Here's to a day filled with joy, reflection, and gratitude. Wishing everyone a safe and spectacular Independence Day from all of us at Prevail, headquartered in historic Philadelphia where the Declaration of Independence and the Constitution were signed all the way back in 1776 and 1787. #FourthOfJuly #IndependenceDay #CelebrateFreedom #Unity #Resilience #Philadelphia #Fireworks #RedWhiteandBlue 

New FDA Guidance Unveiled: Blueprint for Breaking Barriers Big and exciting clinical trial update: The FDA has recently issued its draft guidance on clinical trial diversity, detailing requirements for racial and ethnic diversity action plans. This comprehensive document outlines how to format and submit these plans, emphasizing recruitment goals aligned with disease prevalence. Companies are expected to set recruitment goals for various racial groups, categorized by age and gender, and to explain their rationale and strategies for achieving these goals. This initiative aims to improve representation in clinical trials and enhance the validity of safety and efficacy studies. In what ways do you think the FDA's new draft guidance on clinical trial diversity will influence the development and approval processes of medical products in the future? How can companies adapt their recruitment strategies to align with the FDA's new guidelines? “Participants in clinical trials should be representative of the patients who will use the medical products,” says Robert Califf, the FDA commissioner. “The agency’s draft guidance is an important step—and one of many ongoing efforts—to address the participation of underrepresented populations in clinical trials to help improve the data we have about patients who will use the medical products if approved.” Read more in the article in the comment below. #FDA #ClinicalTrials #DiversityInResearch #HealthcareEquity #MedicalResearch #FDAguidance #InclusiveTrials #PatientRepresentation #HealthcareDiversity #ResearchDiversity #TrialRecruitment